These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 18713562)

  • 1. MS in Latin America.
    Correale J
    Int MS J; 2008 Mar; 15(1):3-5. PubMed ID: 18713562
    [No Abstract]   [Full Text] [Related]  

  • 2. Latitudinal prevalence gradient of multiple sclerosis in Latin America.
    Risco J; Maldonado H; Luna L; Osada J; Ruiz P; Juarez A; Vizcarra D
    Mult Scler; 2011 Sep; 17(9):1055-9. PubMed ID: 21551216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis in Latin America.
    Corona T; Román GC
    Neuroepidemiology; 2006; 26(1):1-3. PubMed ID: 16254448
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple sclerosis in Latin America: reality and challenge.
    Rivera VM
    Neuroepidemiology; 2009; 32(4):294-5. PubMed ID: 19246934
    [No Abstract]   [Full Text] [Related]  

  • 5. MS in Latin America.
    Luetic G
    Int MS J; 2008 Mar; 15(1):6-11. PubMed ID: 18713563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards establishing MS prevalence in Latin America and the Caribbean.
    Melcon MO; Melcon CM; Bartoloni L; Cristiano E; Duran JC; Grzesiuk AK; Fragoso YD; Brooks JB; Díaz V; Romero García KM; Cabrera Gomez JA; Abad P; Islas MA; Gracia F; Diaz de Bedoya VF; Ruiz ME; Hackembruch JH; Oehninger C; Ketzoian CN; Soto A;
    Mult Scler; 2013 Feb; 19(2):145-52. PubMed ID: 22492129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Sclerosis in Latin Americans: Genetic Aspects.
    Rivera VM
    Curr Neurol Neurosci Rep; 2017 Aug; 17(8):57. PubMed ID: 28639238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical features of multiple sclerosis in Latin America.
    Ojeda E; Díaz-Cortes D; Rosales D; Duarte-Rey C; Anaya JM; Rojas-Villarraga A
    Clin Neurol Neurosurg; 2013 Apr; 115(4):381-7. PubMed ID: 23273381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of multiple sclerosis prevalence and phenotype in Latin America.
    Negrotto L; Correale J
    Mult Scler Relat Disord; 2018 May; 22():97-102. PubMed ID: 29649790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis care units in Latin America: Consensus recommendations about its objectives and functioning implementation.
    Cristiano E; Abad P; Becker J; Carrá A; Correale J; Flores J; Fruns M; Garcea O; Garcia Bónitto J; Gracia F; Hamuy F; Navas C; Patrucco L; Rivera V; Velazquez M; Rojas JI
    J Neurol Sci; 2021 Oct; 429():118072. PubMed ID: 34509134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic armamentarium and health system coverage of multiple sclerosis in Latin America.
    Gracia F; Armien B
    Neuroepidemiology; 2012; 38(4):217-8. PubMed ID: 22555542
    [No Abstract]   [Full Text] [Related]  

  • 12. Houston's Methodist Hospital targets international multiple sclerosis patients.
    Campbell S
    Health Care Strateg Manage; 1996 Dec; 14(12):13. PubMed ID: 10162820
    [No Abstract]   [Full Text] [Related]  

  • 13. Biological and nonbiological complex drugs for multiple sclerosis in Latin America: regulations and risk management.
    Carrá A; Macías Islas MA; Tarulla A; Bichuetti DB; Finkelsztejn A; Fragoso YD; Árcega-Revilla R; Cárcamo Rodríguez C; Durán JC; Bonitto JG; León R; Oehninger Gatti C; Orozco G; Vizcarra Escobar D
    Expert Rev Neurother; 2015 Jun; 15(6):597-600. PubMed ID: 25924772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis in Caucasians and Latino Americans.
    Aguirre-Cruz L; Flores-Rivera J; De La Cruz-Aguilera DL; Rangel-López E; Corona T
    Autoimmunity; 2011 Nov; 44(7):571-5. PubMed ID: 21875378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of relapsing-remitting multiple sclerosis in Latin America: practical recommendations for treatment optimization.
    Correale J; Abad P; Alvarenga R; Alves-Leon S; Armas E; Barahona J; Buzó R; Corona T; Cristiano E; Gracia F; Bonitto JG; Macías MA; Soto A; Vizcarra D; Freedman MS
    J Neurol Sci; 2014 Apr; 339(1-2):196-206. PubMed ID: 24607335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent risk of multiple sclerosis in two anabaptist communities in America.
    Lauer K
    Med Hypotheses; 2006; 67(4):969-74. PubMed ID: 16759820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendations for optimising the treatment of multiple sclerosis in Latin America].
    Cristiano E; Arcega R; Correale J; Gabbay AA; Lander-Delgado R; Macias-Islas MA; Palacios E; Patrucco L; Rivera-Olmos V; Soto A
    Rev Neurol; 2007 Apr 16-30; 44(8):494-8. PubMed ID: 17455164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic susceptibility to multiple sclerosis (MS). INSERM Network of Clinical Research on the Genetic Susceptibility to MS].
    Fontaine B
    Rev Neurol (Paris); 1998 Sep; 154(8-9):601-5. PubMed ID: 9809375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of familial multiple sclerosis in Hungary.
    Fricska-Nagy Z; Bencsik K; Rajda C; Füvesi J; Honti V; Csépány T; Dobos E; Mátyás K; Rózsa C; Komoly S; Vécsei L
    Mult Scler; 2007 Mar; 13(2):260-1. PubMed ID: 17439894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke in Latin America.
    Camargo EC; Bacheschi LA; Massaro AR
    Neuroimaging Clin N Am; 2005 May; 15(2):283-96, x. PubMed ID: 16198941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.